| Short Description : | Cytokeratin 7 Blocking Peptide is synthetically produced from the 10-60 aa sequence and is suitable for use in western blot applications. |
| Applications: | Immunodepletion/Immunocompetition |
| Note: | STRICTLY FOR FURTHER SCIENTIFIC RESEARCH USE ONLY (RUO). MUST NOT TO BE USED IN DIAGNOSTIC OR THERAPEUTIC APPLICATIONS. |
| Formulation: | Liquid form at 2.5mg/ml concentration in PBS. Up to 5% DMSO can be added. Orders with >1mg can be supplied in lyophilized powder form, or in buffer of choice. |
| Storage Instruction: | Store at-20°C for long term storage. Avoid freeze-thaw cycles. |
| Immunogen: | Synthetic peptide taken within amino acid region 10-60 on human keratin, type II cytoskeletal 7 protein. |
| Immunogen Region: | 10-60 aa |
| Background | Serves to block interferon-dependent interphase and stimulates DNA synthesis. Plays a role in the translational regulation of human papillomavirus type 16 E7 mRNA. |
Information sourced from Uniprot.org